9 minutes agoFear of a second wave with Ovid 19 increases demand for flu vaccine
Periskopi(6 years ago)
(6 years ago)US pharmaceuticals are preparing for an increase in the number of vaccines during the flu season that begins in October, hoping to contain tens of thousands of serious cases that could coincide with a second wave of coronary infections. Pharmacies network “CVS”, one of the largest in [...]
US pharmaceuticals are preparing for an increase in the number of vaccines during the flu season that begins in October, hoping to contain tens of thousands of serious cases that could coincide with a second wave of coronary infections.
Pharmacies network “CVS”, one of the largest in the country, announced that he is working to provide enough vaccines to meet the growing demand. Likewise, the rival pharmacies network “Rite Aid” has ordered 40 percent more vaccines to meet the requirements. Pharmaceuticals “Walmart” and “Walgrees” also announced they expect an increase in the demand for the flu vaccine. The vaccine manufacturers suggested that demand has increased by 10 percent.
According to a survey conducted from May 13th to May 19th by agency “Reuters” and company “Ipsos”, which included 4,428 people, about 60 percent of Americans plan to vaccinate against the flu in the fall. Normally, less than half of Americans choose to be vaccinated.
U.S. Centers for Disease Control and Prevention recommend the flu vaccine for all over six months. The vaccine does not protect you from COVID-19, but public health officials say it will be essential to prevent overload in hospitals with flu and COVID-19. In the meantime (coff) in the United States, the number of infected reached 1 million and 660 thousand, while the death toll of over 98 thousand.
